Streetbeat News

Stock Prices

LYFT

UBER

Wedbush analysts have increased their price target on Uber Technologies Inc (UBER) from $67 to $78, maintaining an 'outperform' rating after the company reported a strong fourth-quarter performance and provided an optimistic earnings forecast for Q1 2024. Uber's Q4 adjusted EBITDA was $1.3 billion with total revenue of $9.9 billion, exceeding consensus estimates. The company anticipates 18-22% year-on-year booking growth and adjusted EBITDA between $1.26 billion and $1.34 billion for Q1 2024. Analyst Dan Ives praised Uber's turnaround and market share gains, contrasting it with Lyft's performance.

Portfolio Pulse from Anan Ashraf

February 08, 2024 | 11:27 am

ARES

Ares Management reported Q4 sales of $703.49M, which fell short of the expected $864.54M estimate. This underperformance could signal potential concerns for investors regarding the company's revenue generation capabilities in the near term.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:17 am

DUK

Duke Energy reported Q4 adjusted EPS of $1.51, missing the $1.54 estimate, and sales of $7.21B, missing the $7.49B estimate. This represents a 36.04% increase in earnings but a 1.89% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:09 am

HAE

Haemonetics has updated its sales growth expectations, now anticipating a 10%-12% increase in both reported and organic sales, up from the previously expected 8%-10% growth. This revision indicates a positive outlook for the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:08 am

DIS

Deutsche Bank analyst Bryan Kraft maintains a Buy rating on Walt Disney (NYSE:DIS) and raises the price target from $116 to $125, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:06 am

RBLX

Barclays analyst Ross Sandler has upgraded Roblox (NYSE:RBLX) from Underweight to Equal-Weight and increased the price target from $26 to $46.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:05 am

PBH

Prestige Consumer Healthcare has increased its diluted EPS guidance for 2023 to approximately $4.33, up from the previous range of $4.27-$4.32, surpassing the consensus estimate of $4.32.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:05 am

PBH

Prestige Consumer (NYSE:PBH) reported Q3 earnings of $1.06 per share, surpassing the $1.04 estimate, and sales of $282.74M, beating the $280.25M estimate. This represents a 1.92% increase in earnings and a 2.62% increase in sales over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:03 am

HAE

Haemonetics (NYSE:HAE) reported Q3 adjusted EPS of $1.04, surpassing the $0.94 estimate, and sales of $336.25M, exceeding the $320.29M estimate. This represents a 22.35% increase in earnings and a 10.14% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:02 am

AXTA

Axalta Coating Systems (AXTA) reported Q4 adjusted EPS of $0.43, missing the consensus estimate of $0.44 by 2.27%. However, their quarterly sales of $1.30B exceeded the $1.28B estimate by 1.33%, marking a 4.85% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 11:01 am